Tag:
Votubia
Latest Headlines
Latest Headlines
Novartis gets final EC nod for Votubia
Novartis ( $NVS ) has won European approval for Votubia as a treatment for a rare type of brain tumor known as subependymal giant cell astrocytoma associated with tuberous sclerosis complex. With the
Novartis drug gets CHMP nod for new use
The Novartis drug everolimus looks to be racking up markets for its third brand name. Marketed as a treatment for kidney and pancreatic cancer under the name Afinitor and as an organ rejection drug
